Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes
Restricted accessResearch articleFirst published online May, 2021
Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes
Epicardial adipose tissue has a paracrine effect, enhancing coronary artery atherosclerotic plaque development. This study evaluated epicardial fat volume (EFV), adipokines, coronary atherosclerosis, and adverse cardiovascular events in a cohort of asymptomatic patients with type 2 diabetes mellitus (T2DM). Epicardial fat volume was calculated using data from computed tomography coronary angiograms. Adipokines and inflammatory cytokines were also assayed and correlated with EFV. Epicardial fat volume was also assessed as a predictor of coronary artery calcium (CAC) score, number of coronary artery plaques, and significant plaque (>50% luminal stenosis). Data from the EFV analysis were available for 221 (85.7%) participants. Median EFV was 97.4 cm3, mean body mass index was 28.1 kg/m2, and mean duration of T2DM was 13 years. Statistically significant, but weak, correlations were observed between several adipokines, inflammatory cytokines, and EFV. Epicardial fat volume was a significant univariate (P = .01), but not multivariate, predictor of the number of coronary plaques, but not of CAC score or significant plaque. After a mean follow-up of 22.8 months, 12 adverse cardiovascular events were reported, exclusively in participants with EFV >97.4 cm3. Epicardial fat volume has limited utility as a marker of coronary artery plaque in patients with T2DM and is weakly correlated with adipokine expression.
LimSDespresJPKohKK. Prevention of atherosclerosis in overweight/obese patients: in need of novel multi-targeted approaches. Circ J. 2011;75:1019–27.
2.
XuHBarnesGTYangQ, et al.Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.
3.
KatagiriHYamadaTOkaY. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res. 2007;101:27–39.
4.
GruzdevaOBorodkinaDUchasovaEDylevaYBarbarashO. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018;17:218–27.
5.
IacobellisGBarbaroG. The double role of epicardial adipose tissue as pro-and anti-inflammatory organ. Hormon Metab Res. 2008;40:442–5.
6.
MazurekTZhangLZalewskiA, et al.Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.
7.
BakerARSilvaNFQuinnDW, et al.Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.
8.
ChengKHChuCSLeeKT, et al.Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obesity (Lond). 2008;32:268–74.
9.
PouKMMassaroJMHoffmannU, et al.Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116:1234–41.
10.
FantuzziGMazzoneT. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007;27:996–1003.
11.
YudkinJSEringaEStehouwerCD. Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365:1817–20.
12.
NicholsJHSamyBNasirK, et al.Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J Cardiovasc Comput Tomogr. 2008;2:288–95.
13.
RositoGAMassaroJMHoffmannU, et al.Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605–13.
14.
WangCPHsuHLHungWC, et al.Increased epicardial adipose tissue volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf). 2009;70:876–82.
15.
PierdomenicoSDPierdomenicoAMCuccurulloFIacobellisG. Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. Am J Cardiol. 2013;11:73–8.
16.
NagyEJermendyALMerkelyBMaurovich-HorvatP. Clinical importance of epicardial adipose tissue. Arch Med Sci. 2017;13:864–74.
17.
AhmadiNNabaviVYangE, et al.Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol. 2010;17:1518–24.
18.
NakanishiRRajaniRChengVY, et al.Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis. 2011;218:363–8.
19.
YerramasuADeyDVenurajuS, et al.Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis. 2012;220:223–30.
20.
MahabadiAALehmanNKalschH, et al.Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging. 2014;7:909–16.
21.
KimBJKimBSKangJH. Echocardiographic epicardial fat thickness is associated with coronary artery calcification: Results from the CAESAR Study. Circ J. 2015;79:818–24.
22.
AbazidRMSmetteiOAKatteaMO, et al.Relation between epicardial fat and subclinical atherosclerosis in asymptomatic individuals. J Thorac Imaging. 2017;32:378–82.
23.
GorterPMde VosAMvan der GraafY, et al.Relation of epicardial and peri-coronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol. 2008;102:380–5.
24.
RajaniRShmilovichHNakazatoR, et al.Relationship of epicardial fat volume to coronary plaque, severe coronary stenosis, and high-risk coronary plaque features assessed by coronary CT angiography. J Cardiovasc Comput Tomogr. 2013;7:125–32.
25.
NerlekarNBrownAJMuthalalyRG, et al.Association of epicardial adipose tissue and high-risk plaque characteristics: A systematic review and meta-analysis. J Am Heart Assoc. 2017;6: pii: e006379.
26.
GreifMLeberAWSaamT, et al.Determination of pericardial adipose tissue increases the prognostic accuracy of coronary artery calcification for future cardiovascular events. Cardiology. 2012;121:220–7.
27.
ForouzandehFChangSMMuhyieddeenK, et al.Does quantifying epicardial and intrathoracic fat with noncontrast computed tomography improve risk stratification beyond calcium scoring alone?Circ Cardiovasc Imaging. 2013;6:58–66.
28.
GoellerMAchenbachSMarwanM, et al.Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. J Cardiovasc Comput Tomogr. 2018;12:67–73.
29.
DingJHsuFCHarrisTB, et al.The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009;90:499–504.
30.
ChengVYDeyDTamarappooB, et al.Pericardial fat burden on ECG-gated non-contrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. J Am Coll Cardiol. 2010;3:35–60.
31.
WangCPHsuHLHungWC, et al.Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf). 2009;70:876–82.
32.
LiYLiuBJingX, et al.Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18:3.
33.
AchenbachSRaggiP. Imaging of coronary atherosclerosis by computed tomography. Eur Heart J. 2010;31:1442–8.
34.
LeipsicJAbbaraSAchenbachS, et al.SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8:342–58.
35.
VenurajuSJeevarethinamAMehtaVS, et al.Predicting severity of coronary artery disease in patients with diabetes using endothelial function measured with peripheral arterial tonometry: PROCEED Study. Angiology. 2019;70:613–20.
36.
AhnSGLimHSJoeDY, et al.Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008;94:e7.
37.
GrovesEMErandeASLeC, et al.Comparison of epicardial adipose tissue volume and coronary artery disease severity in asymptomatic adults with versus without diabetes mellitus. Am J Cardiol. 2014;114:686–91.
38.
TanamiYJinzakiMKishiS, et al.Lack of association between epicardial fat volume and extent of coronary artery calcification, severity of coronary artery disease, or presence of myocardial perfusion abnormalities in a diverse, symptomatic patient population: results from the CORE320 multicenter study. Circ Cardiovasc Imaging. 2015;8:e002676.
39.
VersteylenMOTakxRAJoosenIA, et al.Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain. Eur Heart J Cardiovasc Imaging. 2012;13:517–23.
40.
MiaoCChenSDingJ, et al.The association of pericardial fat with coronary artery plaque index at MR imaging: The Multi-Ethnic Study of Atherosclerosis (MESA). Radiology. 2011;261:109–15.
41.
Rodriguez-GranilloGACarrascosaPDeviggianoA, et al.Pericardial fat volume is related to atherosclerotic plaque burden rather than severity. Eur Heart J. 2017;18:795–801.
42.
Rodriguez-GranilloGAReynosoECapunayCCarpioJCarrascosaP. Pericardial and visceral, but not total body fat, are related to global coronary and extra-coronary atherosclerotic plaque burden. Int J Cardiol. 2018;260:204–10.
43.
GargSKLinFKandulaN, et al.Ectopic fat depots and coronary artery calcium in South Asians compared with other racial/ethnic groups. J Am Heart Assoc. 2016;5: pii: e004257.
44.
ShahADKandulaNRLinF, et al.Less favorable body composition and adipokines in South Asians compared to other U.S. ethnic groups: Results from the MASALA and MESA studies. Int J Obesity (Lond). 2016;40:639–45.
45.
AdamsDBNarayanOMunnurRK, et al.Ethnic differences in coronary plaque and epicardial fat volume quantified using computed tomography. Int J Cardiovasc Imaging. 2017;33:241–9.
46.
Mongraw-ChaffinMGujralUPKanayaAMKandulaNRCarrJJAndersonCAM. Relation of ectopic fat with atherosclerotic cardiovascular disease risk score in South Asians living in the United States (from the Mediators of Atherosclerosis in South Asians Living in America [MASALA] Study). Am J Cardiol. 2018;121:315–21.
47.
IacobellisGPistilliDGucciardoM, et al.Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29:251–5.
48.
ShimabukuroMHirataYTabataM, et al.Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:1077–84.
49.
VenurajuSMLahiriAJeevarethinamA, et al.Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study. Cardiovasc Diabetol. 2019;18:51.
50.
EdsfeldtAGonçalvesIGrufmanH, et al.Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes. Arterioscler Thromb Vasc Biol. 2014;34:2143–50.
51.
AlexopoulosNMelekBHArepalliCD, et al.Effect of intensive versus moderate lipid - lowering therapy on epicardial adipose tissue in hyperlipidemic post - menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol. 2013;61:1956–61.
